1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        APAC Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        APAC Biopharmaceutical Contract Manufacturing Market – By Source

1.3.4        APAC Biopharmaceutical Contract Manufacturing Market – By Country

2.           APAC Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Biopharmaceutical Contract Manufacturing – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        APAC – PEST Analysis

4.3         Expert Opinion

5.           APAC Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Outsourcing by Pharmaceutical Companies

5.1.2        Increasing Demand for Biologics

5.2         Market Restraints

5.2.1        Growing Competition in Industry

5.3         Market Opportunities

5.3.1        Emerging Markets

5.4         Future Trends

5.4.1        Consolidation in Pharmaceutical CMO Industry

5.4.2        COVID-19 Pandemic

5.5         Impact Analysis

6.           Biopharmaceutical Contract Manufacturing Market – APAC Analysis

6.1         APAC Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

7.           APAC Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1         Overview

7.2         APAC Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

7.3         Biologics

7.3.1        Overview

7.3.2        Biologics: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Monoclonal Antibodies

7.3.2.1.1          Overview

7.3.2.1.2          Monoclonal Antibodies: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Recombinant Proteins

7.3.2.2.1          Overview

7.3.2.2.2          Recombinant Proteins: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Vaccines

7.3.2.3.1          Overview

7.3.2.3.2          Vaccines: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4          Others

7.3.2.4.1          Overview

7.3.2.4.2          Others: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Biosimilar

7.4.1        Overview

7.4.2        Biosimilar: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.           APAC Biopharmaceuticals Contract Manufacturing Market – By Service

8.1         Overview

8.2         APAC Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

8.3         Process Development

8.3.1        Overview

8.3.2        Process Development: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Downstream Processing

8.3.2.1.1          Overview

8.3.2.1.2          Downstream Processing: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Upstream Processing

8.3.2.2.1          Overview

8.3.2.2.2          Upstream Processing: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Fill and Finish Operations

8.4.1        Overview

8.4.2        Fill and Finish Operations: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Analytical and QC Studies

8.5.1        Overview

8.5.2        Analytical and QC Studies: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Packaging

8.6.1        Overview

8.6.2        Packaging: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.           APAC Biopharmaceuticals Contract Manufacturing Market – By Source

9.1         Overview

9.2         APAC Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

9.3         Mammalian

9.3.1        Overview

9.3.2        Mammalian: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Microbial/Non-Mammalian-Based Biologics

9.4.1        Overview

9.4.2        Microbial/Non-Mammalian-Based Biologics: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.        APAC Biopharmaceutical Contract Manufacturing Market – Country Analysis

10.1      APAC: Biopharmaceutical Contract Manufacturing Market

10.1.1     Overview

10.1.2     APAC: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.1.2.1       China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       China: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.1.2.1     China: Biologics Market, 2019-2028 (USD Million)

10.1.2.1.3       China: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.1.3.1     China: Process Development Market, 2019-2028 (USD Million)

10.1.2.1.4       China: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.2       Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.2.2.1     Japan: Biologics Market, 2019-2028 (USD Million)

10.1.2.2.3       Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.2.3.1     Japan: Process Development Market, 2019-2028 (USD Million)

10.1.2.2.4       Japan: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.3       India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       India: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.3.2.1     India: Biologics Market, 2019-2028 (USD Million)

10.1.2.3.3       India: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.3.3.1     India: Process Development Market, 2019-2028 (USD Million)

10.1.2.3.4       India: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.4       South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1       South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2       South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.4.2.1     South Korea: Biologics Market, 2019-2028 (USD Million)

10.1.2.4.3       South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.4.3.1     South Korea: Process Development Market, 2019-2028 (USD Million)

10.1.2.4.4       South Korea: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.5       Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1       Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2       Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.5.2.1     Australia: Biologics Market, 2019-2028 (USD Million)

10.1.2.5.3       Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.5.3.1     Australia: Process Development Market, 2019-2028 (USD Million)

10.1.2.5.4       Australia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.6       Rest of APAC: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1       Rest of APAC: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2       Rest of APAC: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.6.2.1     Rest of APAC: Biologics Market, 2019-2028 (USD Million)

10.1.2.6.3       Rest of APAC: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.6.3.1     Rest of APAC: Process Development Market, 2019-2028 (USD Million)

10.1.2.6.4       Rest of APAC: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

11.        APAC Biopharmaceutical Contract Manufacturing Market – Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      THERMO FISHER SCIENTIFIC INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      General Electric Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      MERCK KGAA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Lonza

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Samsung Biologics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      AbbVie Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      WUXI BIOLOGICS

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Ajinomoto Co. Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             APAC Biopharmaceutical Contract Manufacturing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 3.             China Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 4.             China Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             China Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 6.             China Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 13.          India Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 14.          India Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 15.          India Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 16.          India Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 17.          India Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 22.          South Korea Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 23.          Australia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 24.          Australia Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 25.          Australia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 26.          Australia Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 27.          Australia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of APAC Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of APAC Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of APAC Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of APAC Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of APAC Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 33.          Organic Developments Done By Companies

Table 34.          Inorganic Developments Done By Companies

Table 35.          Glossary of Terms, APAC Biopharmaceutical Contract Manufacturing Market

LIST OF FIGURES

Figure 1.           APAC Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           APAC Biopharmaceutical Contract Manufacturing Segmentation, By Country

Figure 3.           APAC Biopharmaceutical Contract Manufacturing Market Overview

Figure 4.           Biologics Segment Held Largest Share Of Product In APAC Biopharmaceutical Contract Manufacturing Market

Figure 6.           China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 8.           APAC PEST Analysis

Figure 9.           APAC Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 10.        APAC Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028

Figure 11.        APAC Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

Figure 12.        Biologics: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Monoclonal Antibodies: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Recombinant Proteins: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Vaccines: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Others: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Biosimilar: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        APAC Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

Figure 19.        Process Development: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Downstream Processing: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Upstream Processing: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Fill and Finish Operations: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Analytical and QC Studies: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Packaging: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

Figure 26.        Mammalian: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Microbial/Non-Mammalian-Based Biologics: APAC Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        APAC: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

Figure 29.        APAC: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

Figure 30.        China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Rest of APAC: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)